|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||88.06 - 88.91|
|52 Week Range||81.18 - 94.67|
|PE Ratio (TTM)||15.79|
|Earnings Date||Jan 18, 2018 - Jan 22, 2018|
|Forward Dividend & Yield||2.76 (3.11%)|
|1y Target Est||92.32|
Kevin O’Leary, O’Shares ETFs chairman and P&G shareholder, discusses why he wants Trian's Nelson Peltz on the board at Procter & Gamble.
Former Medtronic CEO Bill George and Nik Mody, RBC Capital Markets analyst, discuss the news that Proctor & Gamble is reportedly challenging the shareholder vote that narrowly elected activist Nelson Peltz to its board.
The consumer products company said on Wednesday it has not yet decided to launch a formal challenge to the results, which are still preliminary, but is reviewing a count performed by IVS Associates Inc to make sure it is accurate. In response, Peltz’s firm, Trian Fund Management, said it was disappointed that P&G continues to question the outcome, which handed him a victory with a margin of just 0.0016 percent of shares outstanding. “Regardless of how they voted, P&G shareholders should be concerned that P&G has opted to waste further time and shareholder money contesting the official tabulation of the independent Inspector,” Trian said in a statement.
Procter & Gamble (PG) is reportedly challenging the proxy vote recount that gave Trian Partners' Nelson Peltz the win -- that's right, P&G wants a recount of the recount. IVS Associates data showed that the activist investor, seeking a seat on P&G's board, edged out his opponent by 43,000 shares or 0.0016%. Early October, P&G released preliminary results showing it won by a narrow margin.
The Procter & Gamble Company today shared that P&G has not launched a challenge to the preliminary proxy vote results. As part of the normal process, the IVS tabulation results are preliminary and are going through a customary review to ensure a final and accurate count.
Procter & Gamble said it is continuing to review the official tally of the hotly contested proxy contest with activist Nelson Peltz but hasn’t decided whether to formally challenge the results, which showed ...
Trian Fund Management, the investment firm that fought to get co-founder Nelson Peltz elected to Procter & Gamble Co.’s board, criticized the consumer-products giant for contesting his narrow victory.
Activist investor Nelson Peltz won a seat on P&G's board by a margin of 0.0016% in a narrow recount. Now, P&G is challenging the tally.
Peltz, who as CEO of Trian Fund Management oversees P&G stock worth $3.5 billion, had refused to concede the election, claiming the vote was too close to call. Both P&G and Trian are entitled to have their solicitors visually inspect the ballots cast by shareholders.
Make sure those closest to you start the New Year looking and feeling great. Every woman has her own beauty routine that works for her and makes her feel ready for the day ahead, but your loved one deserves to feel more than just ready, she should look and feel her best every single day.
The Zacks Analyst Blog Highlights: Walmart, NVIDIA, Procter & Gamble, Phillips 66 and AstraZeneca
With Thanksgiving and Black Friday nearly upon us, with 2018 lingering just beyond, it’s time for investors to consider new portfolio additions for December and the year to come.
The 10 most commonly used products in the world are a collection of items that virtually none of us can live without. No matter where one goes in the world, the majority of these products will be found there and will be just as vital to the locals’ lives. Something that became glaring to us […]